Abstract:Objective To examine the relationship between occurrence of hyperlipidemia. plasma homocysteine and polymorphisms of methyleneletra hydrotblate reductase (MTHFR) gene and methionine synthase (MS) gene. Methods A total of 192 hyperlipidemia patients were selected and divided into hypercholesterolemia group, hypertriglyceridemia group. and combined hyperlipidemia group. Another 208 normal individuals were selected as control. Total plasma homocysteine (tHcy) concentration was measured by high-performance liquid chromatography (HPLC). Lipid profiles were measured for all Subjects. The polymorphisms of MTHFR gene C677T and MS gene A2756G were analyzed by PCR-RFLP. Results The tHcy concentration in the combined hyperlipidemia patients was significantly higher than that in the control ( 15.95 mu mol/L vs 13.43 mu mol/L, P<0.05). The prevalence of hyperhomocysteinemia (HHcy) in the combined hyperlipidemia group was significantly higher than that in the control (42.2% vs 23.0%, P=0.015), with the odds ratio (OR) of 3.339 (95%Cl: 1.260-8.849). The hyperlipidemia patients with HHcy had a higher concentration of total cholesterol (TC) than that in the normal tHcy patients (5.67 +/- 0.95 mmol/L vs 5.47 +/- 0.92 mmol/L, P=0.034). There was no significant difference in genotype or allele frequencies of MTHFR C677T between the hyperlipidemic and control groups. The hyperlipidemia patients with MTHFR CT/TT genotype had a higher concentration of triglyceride (TG) than those with CC genotype (2.24 +/- 1.75 mmol/L vs 1.87 +/- 0.95 mmol/L. P<0.05). Individuals with CT/TT genotype had a higher concentration of tHcy than those with 677CC genotype both in the hyperlipidemia group (12.61 +/- 1.24 mu mol/L vs 11.20 +/- 1.37 mu mol/L. P<0.05) and in the control group (14.04 +/- 1.48 mu mol/L vs 12.61 +/- 1.24 mu mol/L, P<0.05). The percentage of MS 2756 GG/AG genotype in the combined hyperlipidemia group was significantly higher than that in the control (26.7% vs 13.0%, P=0.012). with the OR of 3.121 (95%Cl: 1.288-7.651). The hyperlipidemia patients with MS 2756AG/GG genotype had a higher concentration of TC (5.87 +/- 0.89 mmol/L vs 5.46 +/- 0.93 mmol/L. P<0.05) and LDL-C (3.29 +/- 0.81mmol/L vs 2.94 +/- 0.85 mmol/L, P<0.05) than those with AA genotype. However. individuals with 2756AG/GG genotype showed no significant difference in tHcy among those with AA genotype. Conclusion HHcy and MS A2756G mutation may be the risk factors for combined hyperlipidemia. Further Study is needed to confirm the role of HHcy and MS A2756G Mutation in the development of hyperlipidemia.

Change in Plasma Homocysteine Content after Methionine Loading Test and Its Significance in Patients with Coronary Heart Disease

Relationship Between Folate and Methylenetetrahydrofolate Reductase Gene C677T Polymorphisms and Acute Myocardial Infarction

Clinical Significance of Plasma Homocysteine in the Coronary Atherosclerosis Patients

The Study of Association Between Plasma Homocysteine Level and Coronary Heart Disease

Predictive Value of Homocysteine and Serum Ferritin for Coronary Heart Disease

Effects of Homocysteine on Nonalcoholic Fatty Liver Related Disease: A Mendelian Randomization Study

Hyperhomocysteinemia and Hyperlipidemia in Coronary Heart Disease.

Acute hyperhomocysteinaemia promotes activation of both platelets and endothelium in normal subjects

The Correlation Between Plasma Homocysteine and Coronary Lesion

Genetic Polymorphisms of Homocysteine Metabolism Related Enzymes in Patients with Coronary Heart Disease

Changes of Plasma Levels of Homocysteine and MCP-1 in Patients with Coronary Artery Disease

The Study of Plasma Homocysteine Level,the Methylenetetrahydrofolate Reductase (MTHFR) A1298C Polymorphism,the Methionine Synthase (MS) A2756G Polymorphisms and Their Association to Coronary Artery Disease in the Elderly

Association of homocysteine level with biopsy-proven non-alcoholic fatty liver disease: a meta-analysis.

Homocysteine concentration in coronary artery disease and severity of coronary lesions

Relationship Between Plasma Homocysteine Levels and the Severity of Coronary Arterial Lesions

Homocysteine Measurement and Its Clinical Significances

Relations of methionine synthase gene variation with congenital heart disease

Plasma Homocysteine and Gene Polymorphisms Associated with the Risk of Hyperlipidemia in Northern Chinese Subjects

PS042 Risk Factors Associated with Hyperhomocysteinemia Besides Folate in a Chinese Community-Based Population

Relationship of Blood Folate, Vitamin B12 Levels with Coronary Artery Disease

[Effect of Low-Dose Folate Treatment on Plasma Homocystyeine and Chemokine Levels in Patients with Hyperhomocysteinemia].